Fluphenazine decanoate injection for horses

The intravenous route is not FDA approved and is generally not recommended except when no other alternatives are available. Intravenous administration appears to be associated with a higher risk of QT prolongation and torsade de pointes (TdP) than other forms of administration. The manufacturer recommends ECG monitoring for QT prolongation and arrhythmias if IV administration is required. A dose in the range of 1 to 5 mg IV has been suggested, with the dose being repeated at 30 to 60 minute intervals, if needed. A maximum IV dose has not been established. The lowest effective dose should be used in conjunction with conversion to oral therapy as soon as possible.

Fluphenazine decanoate injection for horses

fluphenazine decanoate injection for horses

Media:

fluphenazine decanoate injection for horsesfluphenazine decanoate injection for horsesfluphenazine decanoate injection for horsesfluphenazine decanoate injection for horsesfluphenazine decanoate injection for horses